Cita APA

Agarwal, R., Koenig, K., Rohren, E., & Subbiah, V. (2014). Combined Antiangiogenic and Mammalian Target of Rapamycin Inhibitor Targeted Therapy in Metaplastic Breast Cancer Harboring a PIK3CA Mutation. Korean Breast Cancer Society.

Chicago Style Citation

Agarwal, Rishi, Kimberly Koenig, Eric Rohren, i Vivek Subbiah. Combined Antiangiogenic and Mammalian Target of Rapamycin Inhibitor Targeted Therapy in Metaplastic Breast Cancer Harboring a PIK3CA Mutation. Korean Breast Cancer Society, 2014.

Cita MLA

Agarwal, Rishi, Kimberly Koenig, Eric Rohren, i Vivek Subbiah. Combined Antiangiogenic and Mammalian Target of Rapamycin Inhibitor Targeted Therapy in Metaplastic Breast Cancer Harboring a PIK3CA Mutation. Korean Breast Cancer Society, 2014.